Identifying an Early Improvement Cutoff in Psoriasis Area and Severity Index for Outcome Prediction Across Systemic Treatments
Dermatologic Therapy · 2026-01 · 2026 (1)
DOI: 10.1155/dth/6867179 ↗Kurz gefasst
Fachartikel in der Zeitschrift Dermatologic Therapy, online erschienen am 06.11.2026. Verfasst von Siqi Li und 11 weiteren Autor:innen. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Shanghai Municipal Education Commission, Shanghai Shen Kang Hospital Development Center.
Abstract (Originalsprache)
Background
Early identification of treatment response is clinically important in psoriasis management, as it may facilitate timely treatment modification and reduce exposure to ineffective therapies. Although early improvement in the Psoriasis Area and Severity Index (PASI) has been associated with long‐term outcomes for individual therapies, a broadly applicable early PASI threshold across different treatment modalities in real‐world practice remains unclear.
Objectives
To evaluate the predictive value of early PASI improvement for subsequent PASI90 achievement across multiple psoriasis treatment modalities and to identify a clinically meaningful early PASI response threshold.
Methods
This prospective, multicenter real‐world cohort study (approval no. 2020‐36) included adult patients with moderate‐to‐severe plaque psoriasis receiving methotrexate, phototherapy, interleukin (IL)‐17 inhibitors, or IL‐23 inhibitors. Receiver operating characteristic (ROC) curve analyses were used to evaluate the predictive performance of week‐4 PASI improvement for achieving PASI90 at 3 and 6 months. The optimal early response threshold was identified using the Youden Index. Multivariable logistic regression analyses were conducted to assess the independent association between early PASI response and subsequent PASI90 achievement.
Results
A total of 2023 patients were included in the analysis. The optimal week‐4 PASI improvement threshold for predicting PASI90 at 3 months was 62% for IL‐17 inhibitors, 62% for IL‐23 inhibitors, 59% for methotrexate, and 61% for phototherapy. Multivariable logistic regression analyses further demonstrated that a PASI improvement of approximately 60% at Week 4 was independently associated with a higher likelihood of achieving PASI90 at 3 months.
Conclusions
Achieving PASI60 at Week 4 serves as a consistent early indicator of subsequent PASI90 response across multiple psoriasis treatment modalities. These findings suggest that PASI60 may represent a potentially generalizable early‐response threshold; however, external validation in independent populations is required before its incorporation into routine clinical decision‐making. Trial Registration: Chinese Clinical Trial Registry: ChiCTR2000036186
Förderung
- National Natural Science Foundation of China
- Shanghai Municipal Education Commission
- Shanghai Shen Kang Hospital Development Center
- Program of Shanghai Academic Research Leader
- Fundamental Research Funds for the Central Universities
Zitieren
APA
Li, S., Jiang, Y., Dai, M., Chen, Q., Huang, D., Wang, Y., Hu, Y., Zhang, Y., Lin, S., Zhang, X., Yu, Q., & Shi, Y. (2026). Identifying an Early Improvement Cutoff in Psoriasis Area and Severity Index for Outcome Prediction Across Systemic Treatments. Dermatologic Therapy, 2026(1). https://doi.org/10.1155/dth/6867179
Vancouver
Li S, Jiang Y, Dai M, Chen Q, Huang D, Wang Y, et al. Identifying an Early Improvement Cutoff in Psoriasis Area and Severity Index for Outcome Prediction Across Systemic Treatments. Dermatologic Therapy. 2026;2026(1). doi:10.1155/dth/6867179
BibTeX
@article{Li2026,
author = {Li, Siqi and Jiang, Yuxiong and Dai, Min and Chen, Qianyu and Huang, Dawei and Wang, Yu and Hu, Yifan and Zhang, Yuanwenke and Lin, Suyang and Zhang, Xilin and Yu, Qian and Shi, Yuling},
title = {Identifying an Early Improvement Cutoff in Psoriasis Area and Severity Index for Outcome Prediction Across Systemic Treatments},
journal = {Dermatologic Therapy},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/dth/6867179}
}
EUVIMED